Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Mylan Products Ltd, Station Close, Potters Bar, Hertfordshire, EN6 1TL, United Kingdom
Dalmane 15 mg Capsules.
| Pharmaceutical Form |
|---|
|
Dalmane capsules 15 mg. |
Capsules with opaque grey cap and opaque yellow body with “ICN 15” printed in red on both cap and body, containing 16.4 mg flurazepam monohydrochloride (equivalent to 15 mg flurazepam).
Each capsule contains 114.6 mg lactose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Flurazepam |
Flurazepam is a psychotropic substance from the class of 1,4-benzodiazepines. Flurazepam binds to specific benzodiazepine receptors located on GABA-ergic neurones and potentiates the inhibitory actions of GABA-ergic neurones in the nervous system. Flurazepam is used as a short-term treatment of insomnia. |
| List of Excipients |
|---|
|
15 mg capsules contain the following excipients: Lactose |
PVDC blister packs, amber glass bottles, polythene bags in tins, plastic adept containers, white securitainers and small HDPE bottles, containing 30 capsules.
Not all pack sizes may be marketed.
Mylan Products Ltd, Station Close, Potters Bar, Hertfordshire, EN6 1TL, United Kingdom
PL 46302/0125
03/05/1999
| Drug | Countries | |
|---|---|---|
| DALMANE | Ireland, Malta, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
